Why insider trading matters?

What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.

- Founders of FormWhispers.com
BIOSPECIFICS TECHNOLOGIES CORP (BSTC)
Sector: Healthcare; Industry: Biotechnology

BioSpecifics Technologies Corp., a biopharmaceutical company, develops an injectable collagenase clostridium histolyticum for various indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX and Xiapex brands. BioSpecifics Technologies Corp. was founded in 1957 and is headquartered in Wilmington, Delaware.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-12-02 Endo International plc 10%-Owner Buy 7,344,955 $88.50 $650,028,518 No
2019-09-10 Wegman Toby 10%-Owner, Director Sell 10,000 $55.17 $551,677 No
2019-06-07 Chao Jennifer M Director Sell 459 $58.55 $26,874 No
2019-06-05 Chao Jennifer M Director Sell 5,511 $57.26 $315,543 No
2019-06-03 CALDWELL PATRICK M Principal Financial Officer Sell 6,000 $58.80 $352,800 No
2019-05-29 Chao Jennifer M Director Sell 3,313 $60.74 $201,232 No
2019-05-24 Wegman Mark N Director Sell 7,800 $61.09 $476,502 No
2019-05-22 Mattila Jyrki Director Sell 18,750 $62.06 $1,163,625 Yes
2019-05-22 Wegman Mark N Director Sell 1,200 $63.70 $76,440 No
2019-05-21 Wegman Toby 10%-Owner, Director Sell 5,500 $64.06 $352,353 No
2019-05-21 Wegman Mark N Director Sell 6,000 $64.04 $384,236 No
2019-05-17 Chao Jennifer M Director Sell 4,000 $63.72 $254,860 No
2019-05-15 Gitman Paul Director Sell 5,000 $65.83 $329,150 No
2018-09-11 Wegman Mark N Director Sell 6,500 $57.52 $373,861 No
2018-09-07 Gitman Paul Director Sell 1,000 $57.64 $57,637 No
2018-08-29 Gitman Paul Director Sell 19,000 $49.72 $944,738 No
2018-08-24 Gitman Paul Director Sell 11,825 $51.17 $605,128 No
2018-08-29 Gitman Paul Director Sell 20,000 $49.73 $994,532 No
2018-08-24 Gitman Paul Director Sell 11,825 $51.17 $605,128 No
2018-08-23 Wegman Mark N Director Sell 8,500 $52.63 $447,322 No
2018-08-17 Estate of Edwin H. Wegman 10%-Owner Sell 57,705 $38.22 $2,205,474 No
2018-08-17 Wegman Toby 10%-Owner, Director Sell 2,500 $51.89 $129,728 No
2018-08-17 Wegman Thomas President Sell 23,592 $51.30 $1,210,294 No
2018-08-15 Wegman Thomas President Sell 23,908 $50.81 $1,214,703 No
2016-12-08 Wegman Thomas President Sell 15,000 $49.54 $743,112 No
2016-11-29 Wegman Thomas President Sell 20,000 $48.16 $963,235 No
2016-12-08 Wegman Thomas President Sell 15,000 $49.54 $743,112 No
2016-11-29 Wegman Thomas President Sell 10,000 $48.08 $480,832 No
2016-11-29 Wegman Toby Director Sell 10,000 $48.08 $480,832 No
2016-11-29 Wegman Thomas President Sell 20,000 $48.16 $963,235 No

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.

Insider Smart

SIMON PROPERTY GROUP (SPG) - Bottom fishing the crash could be intimidating, but it can be easier if you know insiders are on your side. Aeppel Glyn, Director of SPG played safe and bought shares in May at $50, but it is not late at all, the stock is now $90.